Literature DB >> 16388328

Risk-reduction surgery decisions in high-risk women seen for genetic counseling.

Jessica A Ray1, Lois J Loescher, Molly Brewer.   

Abstract

Women at greatest risk for hereditary breast and ovarian cancer may consider prophylactic removal of breasts or ovaries as a risk-reduction measure. This report describes uptake of risk-reduction mastectomy (RRM), risk-reduction oophorectomy (RRO), and related factors in 62 high-risk women who received genetic counseling. Seven (11%) participants underwent RRM and 13 (21%) underwent RRO. Of these women, 37% did not have BRCA testing, suggesting other factors influence decisions to undergo surgery. Women who had indicated (pre-genetic counseling) their intent not to have surgery chose not to have surgery. Information received during genetic counseling that women perceived as being most important for influencing risk-reduction surgery decisions was BRCA test result (positive or negative), followed by discussion of family cancer history. Reasons for indecision about risk-reduction surgery included genetic testing results, concerns about surgery, timing in life, and early menopause. The findings enhance our understanding of information that is helpful to women considering this surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388328     DOI: 10.1007/s10897-005-5833-5

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  39 in total

1.  A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.

Authors:  N Hallowell
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

2.  Prophylactic surgery in patients with inherited risk of ovarian cancer.

Authors:  P Morice; P Pautier; S Delaloge
Journal:  Gynecol Oncol       Date:  2001-11       Impact factor: 5.482

3.  American Cancer Society guidelines for breast cancer screening: update 2003.

Authors:  Robert A Smith; Debbie Saslow; Kimberly Andrews Sawyer; Wylie Burke; Mary E Costanza; W Phil Evans; Roger S Foster; Edward Hendrick; Harmon J Eyre; Steven Sener
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

4.  Breast cancer risks for BRCA1/2 carriers.

Authors:  Sholom Wacholder; Jeffery P Struewing; Patricia Hartge; Mark H Greene; Margaret A Tucker
Journal:  Science       Date:  2004-12-24       Impact factor: 47.728

Review 5.  Current status of prophylactic mastectomy.

Authors:  Karthik Ghosh; Lynn C Hartmann
Journal:  Oncology (Williston Park)       Date:  2002-10       Impact factor: 2.990

6.  Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

Authors:  D Schrag; K M Kuntz; J E Garber; J C Weeks
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

7.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

8.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

Review 9.  Current status of prophylactic surgery for hereditary breast and gynecologic cancers.

Authors:  H T Lynch; M J Casey
Journal:  Curr Opin Obstet Gynecol       Date:  2001-02       Impact factor: 1.927

10.  Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy.

Authors:  Pål Møller; Ake Borg; D Gareth Evans; Neva Haites; Marta M Reis; Hans Vasen; Elaine Anderson; C Michael Steel; Jaran Apold; David Goudie; Anthony Howell; Fiona Lalloo; Lovise Maehle; Helen Gregory; Ketil Heimdal
Journal:  Int J Cancer       Date:  2002-10-20       Impact factor: 7.396

View more
  18 in total

1.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

2.  Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.

Authors:  Athena Puski; Shelly Hovick; Leigha Senter; Amanda Ewart Toland
Journal:  J Genet Couns       Date:  2018-03-29       Impact factor: 2.537

3.  Choice of management of southern Chinese BRCA mutation carriers.

Authors:  Ava Kwong; Connie H N Wong; Catherine Shea; Dacita T K Suen; Catherine L Y Choi
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

4.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

Review 5.  Understanding genetic epidemiologic association studies Part 1: fundamentals.

Authors:  Kaye M Reid-Lombardo; Gloria M Petersen
Journal:  Surgery       Date:  2009-12-03       Impact factor: 3.982

6.  Association of shared decision-making with type of breast cancer surgery: a cross-sectional study.

Authors:  Myung Kyung Lee; Dong Young Noh; Seok Jin Nam; Se Hyun Ahn; Byeong Woo Park; Eun Sook Lee; Young Ho Yun
Journal:  BMC Health Serv Res       Date:  2010-02-23       Impact factor: 2.655

7.  Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.

Authors:  Jennifer K Litton; Shannon N Westin; Kaylene Ready; Charlotte C Sun; Susan K Peterson; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Diane C Bodurka; Karen H Lu; Gabriel N Hortobagyi; Banu K Arun
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

8.  Understanding the needs of women considering risk-reducing salpingo-oophorectomy.

Authors:  Carol Cherry; Mary Ropka; Jennifer Lyle; Laura Napolitano; Mary B Daly
Journal:  Cancer Nurs       Date:  2013 May-Jun       Impact factor: 2.592

9.  Ovulation in the absence of the ovarian surface epithelium in the primate.

Authors:  Jay W Wright; Tanja Pejovic; Maralee Lawson; Leigh Jurevic; Theodore Hobbs; Richard L Stouffer
Journal:  Biol Reprod       Date:  2009-11-18       Impact factor: 4.285

10.  Women with BRCA1 or BRCA2 mutations renegotiating a post-prophylactic mastectomy identity: self-image and self-disclosure.

Authors:  Regina H Kenen; Pamela J Shapiro; Liisa Hantsoo; Susan Friedman; James C Coyne
Journal:  J Genet Couns       Date:  2007-10-05       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.